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on health related quality of life. Attention is needed to highlight determinants of 
health related quality of life and to implement policies for better management of 
Type 2 Diabetes Mellitus, particularly in early treatment phases where improving 
Health Related Quality of Life is still possible.
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Objectives: Diabetic foot ulcer (DFU) is a common complication of diabetes and 
not only an important factor of mortality among patients with diabetes but also 
decreases quality of life. Several clinical trials showed that patients with foot 
ulceration have significantly decreased HRQoL as compared to those without 
DFU. Most of these studies used SF-36 for quality of life measures, however it is 
suggested that the results of this HRQoL survey may be confounded by non-foot 
complications of diabetes. The short form of Diabetic Foot Ulcer Scale (DFS-SF) is 
a condition-specific tool, providing comprehensive measurement of DFU impact 
on patients’ QoL. The Polish translation of DFS-SF has undergone a full linguistic 
validation process and showed good psychometric performance in patients with 
DFU. The purpose of this study was to investigate the influence of ulcers healing 
process on HRQoL. MethOds: Assessment of healing process impact on HRQoL 
was performed in patients with active DFU. Wound healing assessment was car-
ried out on two control visits separated with a 6-months period, on the basis of 
wound diameter measurements and PEDIS score. Hypothesis testing was conducted 
using the Student’s t-test (α = 0.05). Results: Data on 120 patients were analyzed 
(mean age: 61.1 years, male: 73%, type 2 diabetes: 87%). The average ulcer size on 
first visit was 5.6 sq cm, and reduced significantly to 2.7 sq cm on second visit. 
Improvement in all six DFS-SF subscales was observed, statistically significant in 
physical health, worried about ulcers/feet and bothered by ulcer care subscales. 
Complete ulcer healing was observed in 42 patients. All six DFS-SF subscales showed 
greater improvement in this subpopulation compared to population without com-
plete ulcer healing, although the difference was not significant. cOnclusiOns: 
In previous study we identified weak negative correlation between ulcer size and 
HRQoL. This study showed that ulcers healing process has significant impact on 
HRQoL of DFU patients.
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Objectives: Understanding immediate improvements in health related quality-
of-life (HRQoL) due to better glycaemic control may help inform decisions relating 
to the management of diabetes. This study investigated the short-term impact on 
HRQoL associated with HbA1c change, body weight change, and the complexity of 
treatment regimen, using time-trade-off (TTO) methodology MethOds: The study 
was performed in three stages: 1) Qualitative telephone interviews with people 
with type 2 diabetes (T2D) in Denmark who experienced a decrease in their HbA1c 
level; 2) A validation survey with people with T2D in Denmark to obtain quantifiable 
knowledge on the short-term effects of a change in HbA1c levels; 3) TTO survey using 
health states based on results from stage 2. ‘Not well-controlled diabetes’ reflected 
an HbA1c average of 11.6%, and ‘well-controlled diabetes’ an HbA1c average of 
7.4%. All other health states were based on ‘well-controlled diabetes’. These health 
states implied change in insulin regimen and change in weight. Respondents were 
either adults with T2D (Sweden) or from the general public (UK and Denmark) and 
were separately randomly allocated to evaluate 6 of the 10 health states through an 
internet-based survey. Results: In total, 4060respondents were available for analy-
sis (UK n= 1777; Denmark n= 1799, Sweden n= 484). ‘Well-controlled diabetes’ was 
associated with a utility of 0.85-0.91 and ‘not well-controlled diabetes’ with utilities 
of 0.71-0.80. The treatment regimen health state associated with the smallest reduc-
tion in utility was the once-daily insulin regimen. As expected, results in all three 
countries suggested that respondents would prefer to lose rather than gain weight 
(utility of 0.87–0.92 for losing 5 kg and 0.88–0.92 for losing 2 kg). cOnclusiOns: A 
simple treatment regimen with fewer injections that improves HbA1c levels, avoids 
weight gain, or even causes weight loss, compared with other treatments, will have 
a positive impact on HRQoL.
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Objectives: The aim of this study was to estimate willingness to pay (WTP) amount 
for one quality adjusted-life years (QALY) in diabetic patients and investigating fac-
tors that associated with it. MethOds: A cross sectional survey with face to face 
interviews was conducted with diabetic patients in Tehran city between June and 
August of 2014 to elicit WTP for QALY as following: First, Current health preferences 
were measured using EuroQol-5D (EQ-5D), visual analogue Scale (VAS) and time 
trade off (TTO) techniques, then a hypothetical scenario using double bounded 
dichotomous choice technique was presented to patients to elicit individual’s maxi-
mum WTP for a treatment that recovering them to full health ,contingent to be 
available. finally, value of QALY was estimated by combining preferences. A regres-
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Objectives: Last few years there is drastic increase in type 2 DM cases especially in 
India. Quality of life is considered as one of the better assessment for management 
of diabetes in recent years. The main objective of the study was to assess the HRQOL 
among the diabetes patients using the EQ-5D (kannada version) and to correlate 
with patient demography, complications and treatment. MethOds: The study was 
carried out in medicine Out Patient Department of a tertiary care hospital for the 
period of 6 months. Patients who have fulfilled the inclusion criteria were enrolled 
in the study and demographical details like name, age, sex, occupation, and medical 
and medication history were collected from the medical record. Patients were inter-
viewed and EQ-5D-3L questionnaire was administered. Data was analysed using 
SPSS ver 20.0. Results: Total of 120 patients were selected as per the inclusion 
criteria, among them majority were males (60% N-72) and mean age was 56.8±10.3 
years.The mean value of TTO and VAS was 0.707± 0.2 and 0.688± 0.16 respectively. 
There was statistically significant relationship between HbA1c level and EQ-5D 
score (p< 0.05). Patients suffering from HTN and cardiovascular complications have 
lower EQ-5D scores than the mean scores, and was statistically significant for HTN 
(p< 0.05). There was significant relationship between EQ-5D score and the presence 
of neuropathy and retinopathy (p< 0.05). Patients with increased number of sub-
jective symptoms such as lethargy, fatigue, body pain, weight loss etc. have lower 
EQ-5D scores (p< 0.05). cOnclusiOns: We observed age wise increase in prevalence 
of diabetes mainly in males. Patient with increased age, increased HbA1C levels, 
presence of complications and increased number of diabetic symptoms showed 
increased problems with different dimensions of EQ-5D. We also observed increased 
age, increased HBA1C, presence of complications and increased number of diabetes 
symptoms will decrease the TTO and VAS scores.
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bAckgROund: Previous studies in patients with primary adrenal insufficiency (PAI) 
on conventional replacement therapy suggest decreased health-related quality of 
life (HRQoL), and that patients report more frequently fatigue, increased anxiety 
and inability to work compared to background population. Objectives: To study 
self-reported health status with EQ-5D in patients with PAI. Patients treated with 
Plenadren (modified-release hydrocortisone) were compared with patients treated 
with immediate release hydrocortisone (IRHC) replacement therapy. MethOds: 
This was a cross-sectional, multi-centre, non-interventional survey of patients 
with PAI receiving Plenadren or immediate release hydrocortisone (IRHC) replace-
ment. subjects: One hundred thirty-four adult patients with PAI of whom 
36 (19 females [53%]) were treated with Plenadren and 98 (77 females [79%]) were 
treated with IRHC, were included. MAin OutcOMe MeAsuRe: HRQoL described 
by the EQ-5D, a generic preference-based measure of health. Results: Patients 
on Plenadren and on IRHC had a mean ± SD age of 53.1 ± 12.7 years and 48.0 ± 13.1 
years, respectively (P= 0.043). The majority of the patients were diagnosed more 
than 5 years ago (69%). The mean ± SD daily Plenadren and IRHC doses were 27.0 ± 
6.8 mg and 26.6 ± 10.9 mg, respectively (P= 0.807). 47% of the Plenadren patients had 
been receiving Plenadren and 82% of the IRHC patients had been receiving IRHC 
for more than 3 years. Patients receiving Plenadren had better HRQoL measured 
by the EQ-5D questionnaire compared to patients replaced with IRHC (0.76 ± 0.18 
vs 0.68 ± 0.18, respectively [P= 0.040]). cOnclusiOns: Replacement therapy with 
Plenadren in patients with PAI confers measurable benefit on HRQoL relative to 
IRHC as estimated by the EQ-5D questionnaire, and may therefore be advantageous 
when compared to IRHC substitution.
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Objectives: This study was aimed to describe the Health Related Quality of 
Life profile of Type 2 Diabetes Mellitus population attending outpatient clinics in 
Pakistan. MethOds: The study was designed as a cross-sectional descriptive sur-
vey. Type 2 diabetic patients attending a tertiary care institute in Sargodha, Pakistan 
were targeted for the study. The EuroQol EQ-5D was used for the assessment of 
Health Related quality of Life and was scored using values derived from the UK 
general population survey. Descriptive statistics were used for the elaboration 
of socio-demographic characteristics. The chi-square test was used to depict the 
possible association between study variables and Health Related Quality of Life. 
Where significant associations were noted, Phi and Cramer’s V constant were used 
for data interpretation accordingly. P < 0.05 was taken as significant. Results: 
Three hundred and ninety two patients were approached for the study. The 
cohort was dominated by males (n= 222, 56.60 %) with 5.58±4.09 years of history 
of Type 2 Diabetes Mellitus. The study highlighted poor Health related Quality of 
Life among patients with Type 2 Diabetes Mellitus (0.471 ± 0.336). Gender, marital 
status, education, monthly income, occupation, location and duration of the dis-
ease was reported to be significantly associated with Health Related Quality of 
Life (P< 0.001). cOnclusiOns: Type 2 Diabetes Mellitus imposes a negative effect 
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more (n= 2), and it caused a reduction in glycosylated hemoglobin (HbA1c) (n= 4). 
The impact of TTM on medication adherence is still unknown. cOnclusiOns: TTM 
helps type 2 diabetic patients self-manage their condition, and to reach their goals, 
hence achieving better clinical outcomes, and quality of life.
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Objectives: To characterise type 2 diabetes (T2DM) patients in the Netherlands 
initiating basal insulin and those intensifying treatment. MethOds: Antidiabetic 
dispensing records were obtained from the Out-patient Pharmacy Database of the 
PHARMO Database Network. New users, i.e. first-time dispensing, of basal insu-
lin only were selected between 2007-2012. Treatment intensification was defined 
as either add-on of GLP-1, bolus insulin or DPP-4i or switch to premixed insulin. 
Demographics and HbA1c before basal insulin start (pre-insulin), at intensification 
and post- intensification were assessed including time to intensification. Results: 
A total of 15,986 T2DM patients initiating basal insulin only (median (IQR) age at start 
basal insulin: 65 (55-74) years, 52% male, 87%, 75% and 51% had a pre-insulin HbA1c 
> 53, > 58 and > 64 mmol/mol, respectively). Overall, 4,945 patients (31%) intensified 
treatment during a median follow-up of 14 months (median (IQR) age at start basal 
insulin: 63 (53-73) years, 50% male, 88%, 78% and 54% had an HbA1c at intensifica-
tion > 53, > 58 and > 64 mmol/mol, respectively). Intensification mostly was add-on 
of bolus insulin (58%) or switch to premixed insulin (39%). Median (IQR) time to 
intensification was 8 (2-15) months. Among patients with an HbA1c > 53, > 58 and 
> 64 mmol/mol at intensification, median (IQR) time to intensification was 12 (5-23), 
12 (5-22) and 12 (5-22) months, respectively. Post-intensification, 32%, 52% and 73% 
of the patients attained an HbA1c of ≤ 53, ≤ 58 and ≤ 64 mmol/mol, respectively, 
with median reduction in HbA1c of 6 mmol/mol. cOnclusiOns: About one third 
of T2DM patients initiating basal insulin intensified their treatment leading to gly-
cemic goal attainments of HbA1c ≤ 53, ≤ 58 and ≤ 64 mmol/mol in 32%, 52% and 73% 
of patients, respectively. Further research might provide more information on the 
underlying reasons and potential barriers for intensifying versus not intensifying, 
such as patient characteristics, co-medication, treatment complexity and occur-
rence of hypoglycaemic events.
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Objectives: To evaluate the clinical and the economic outcomes of a personalized 
care model (PCM) in diabetes mellitus (DM) supported by information and communi-
cations technology (ICT) in the Spanish National Health System (NHS). MethOds: 
We evaluated a PCM in DM proposed by a group of European experts based on 6 
steps: 1.Structured education; 2.Structured self-monitoring of blood glucose (SMBG); 
3.Structured documentation; 4.Structured data analysis; 5.Personalized treatment; 
6.Evaluation of results. A literature review was made to assess the results of inter-
ventions made within the NHS that used the PCM described. Interventions evaluat-
ing type 2 DM (T2DM), type 1 DM (T1DM) and gestational DM were included. The 
health outcomes measured were the variation in HbA1c,the percentage of controlled 
patients, the body mass index and the body weight. The analysis was made from the 
payer’s perspective, considering the direct costs related to the pathology (€ 2015). 
Costs evaluated were: hospital costs, outpatient visits costs, primary care costs, 
emergency care costs and SMBG costs. Results: The review carried out showed 
that the introduction of this PCM in T2DM would result in an increase of up to 18% 
in controlled patients (HbA1c% < 7%) compared with the current model (follow-
up of 12 months). The expected reduction in HbA1c%would be about -0.5%. The 
implementation of the PCM proposed would reduce the cost of T2DM by about 12% 
compared with the current model with reductions of up to 30% in the cost for out-
patient visits. The expected reduction in total direct costs was approximately 12% 
in T1DM and around 14% in gestational DM. cOnclusiOns: The implementation 
of a PCM in DM with ICT support improved or provided equal disease control com-
pared with conventional care and reduced the high costs associated with diabetes. 
ICT enables adaption and changes in the current model of care and potentiate 
self-management strategies.
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Objectives: To identify, describe in detail, and assess the evidence regarding the 
effects of Diabetes Conversation Maps™, an educational tool that engages diabetic 
patients in group discussions about diabetes-related topics, over a range of patient 
outcomes. MethOds: We conducted a systematic literature review of articles 
published since 2005 that evaluated the Maps™ since 2005 using five electronic 
databases, and the reference lists of relevant papers. Non-English languages, non-
journal papers, and studies that only included a description of the Maps™ were 
excluded. A quality assessment of relevant studies was performed. Outcomes were 
grouped into: objective (e.g., HbA1c levels), subjective (e.g., self-efficacy), and health 
behaviors (e.g., medication adherence). Results: Of the 62 studies originally identi-
fied, 13 were included in the final sample. The overall methodological quality of the 
sion analysis was employed to assess impact of socioeconomic,demographic and 
disease- specific variables on WTP for QALY. Results: Totally, 149 patients with 
type 1 and 2 diabetes were included in analysis. Types 1 were younger with higher 
probability of hospitalization and longer diabetes duration. Foot diabetic disease, eye 
disease and hypertensive were the main comorbidities in both types, accordingly. 
Mean willingness to pay per QALY were estimated between 58,982,210-124,675,610 
IRR (Iranian Rials) that is equal 2107-4453 US Dollars. Significantly, patients with 
better health state, higher cost group (as a proxy of income) and inpatients admis-
sion had higher WTP for QALY. cOnclusiOns: Mean WTP per QALY are between 
0.44-.93 times of local Gross Domestic Product (GDP) per capita. According to rec-
ommendation of world health organization on using 1-3 time GDP per capita as a 
threshold value and defined cost-effectiveness categories, our findings, although, 
is closed to one, but do not advocate strongly the proposed range by WHO. Thus, in 
decision making and resource allocation process, WHO recommendation should be 
employed with cautious and more investigation.
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Objectives: Mobile phone SMS is increasingly used as a means of communication 
between patients and their healthcare providers in many countries of the world.We 
investigated mobile phone use and factors associated with willingness-to-pay (WTP) 
for diabetes SMS among patients with type 2 diabetes in Bangladesh. MethOds: 
As part of a randomized controlled study, in 515 patients with type 2 diabetes, 
socioeconomic status, mobile phone use, WTP for diabetes SMS, anthropometry and 
HbA1c were measured. Multivariate regression was used to identify factors associ-
ated with WTP. Results: The median (interquartile range [IQR]) of WTP for diabetes 
SMS was 20 (45) Bangladesh Taka (BDT) (1 BDT ¼ 0.013 US$). WTP was significantly 
higher for males [OR 2.4, 95% CI (1.0–5.7)], patients with household income .50 000 
BDT [4.6 (1.1–20.4)] and those with primary education [5.6 (1.2–26.6)] and secondary 
and higher education [5.2 (1.4–19.6)]. cOnclusiOns: The high proportion of mobile 
phone use and WTP for diabetes SMS are encouraging as possible strategy to use 
such technologies and deserve further evaluation.
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Objectives: The aim of this study was to estimate willingness to pay (WTP) amount 
for one quality adjusted-life years (QALY) in diabetic patients and investigating fac-
tors that associated with it. MethOds: A cross sectional survey with face to face 
interviews was conducted with diabetic patients in Tehran city between June and 
August of 2014 to elicit WTP for QALY as following: First, Current health preferences 
were measured using EuroQol-5D (EQ-5D), visual analogue Scale (VAS) and time 
trade off (TTO) techniques, then a hypothetical scenario using double bounded 
dichotomous choice technique was presented to patients to elicit individual’s maxi-
mum WTP for a treatment that recovering them to full health ,contingent to be 
available. So value of QALY was estimated by combining preferences. A regression 
analysis was employed to investigate impact of individuals’ characteristics and 
disease- specific variables on the WTP for QALY. Results: Totally, 149 patients with 
type 1 and 2 diabetes were included in analysis. Types 1 were younger with higher 
probability of hospitalization and longer diabetes duration. Foot diabetic disease, eye 
disease and hypertensive were the main comorbidities in both types, accordingly. 
Mean willingness to pay per QALY were estimated between 58,982,210-124,675,610 
IRR (Iranian Rials) that is equal 2107-4453 US Dollars. Significantly, patients with bet-
ter health state, higher cost group (as a proxy of income) and inpatients admission 
had higher WTP for QALY. cOnclusiOns: Mean WTP per QALY are between 0.44-.93 
times of local Gross Domestic Product (GDP) per capita. According to recommenda-
tion of world health organization on using 1-3 time GDP per capita as a threshold 
value and defined cost-effectiveness categories, our findings, although, is closed to 
one GDP per capita, but do not advocate strongly the proposed range by WHO. Thus, 
in decision making and resource allocation process, WHO recommendation should 
be employed with cautious and more investigation.
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Objectives: The objective of this study is to assess the use of transtheoretical model 
(TTM) in improving self-management activities in type 2 diabetic patients. Self-
management activities include following a healthier diet, exercising more regularly, 
and an enhanced medication adherence. MethOds: Pubmed, Medline, Science 
direct, and Cochrane databases were searched with predefined terms relating to 
TTM interventions for type 2 diabetic patients. All study designs were included. 
The systematic search was conducted in March 2015. Two reviewers independently 
assessed the relevance of abstracts identiﬁed, extracted the data and undertook 
quality analysis. The review was done using PRISMA checklist. Results: Ten studies 
met the criteria for inclusion in the review. All studies demonstrated some positive 
outcomes self-management due to implementing TTM. In six studies the patients 
reached the action or maintenance stage in the TTM cycle after the TTM interven-
tion. Moreover, TTM was able to help patients follow a healthier diet (n= 5), exercise 
